Maxigen Biotech (TPE:1783) 3-Year Book Growth Rate : 12.60% (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Maxigen Biotech 3-Year Book Growth Rate?

Maxigen Biotech's Book Value per Share for the quarter that ended in Sep. 2024 was NT$14.98.

During the past 12 months, Maxigen Biotech's average Book Value per Share Growth Rate was -2.70% per year. During the past 3 years, the average Book Value per Share Growth Rate was 12.60% per year. During the past 5 years, the average Book Value per Share Growth Rate was 9.00% per year. During the past 10 years, the average Book Value per Share Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Maxigen Biotech was 19.60% per year. The lowest was -4.50% per year. And the median was 5.25% per year.

Competitive Comparison of Maxigen Biotech's 3-Year Book Growth Rate

For the Medical Instruments & Supplies subindustry, Maxigen Biotech's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maxigen Biotech's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Maxigen Biotech's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Maxigen Biotech's 3-Year Book Growth Rate falls into.

Maxigen Biotech 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Maxigen Biotech (TPE:1783) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Maxigen Biotech 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Maxigen Biotech's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Maxigen Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 88, Keji 1st Road, Guishan District, Taoyuan City, TWN, 333

Website

https://www.mbi.com.tw

Maxigen Biotech Inc specializes in the developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products. It provides medical devices for orthopedic, ophthalmic, dental, and surgical applications. Skincare product categories include mask series, facial cleansing series, and body care series. The biomedical products segment is mainly engaged in the manufacturing and sales of collagen and bone materials, which forms the majority chunk of the revenue of the group. The consumer products segment is engaged in the manufacturing and sales of beauty care products. It generates the majority of the revenue from the Biomedical products segment.

Maxigen Biotech Headlines

No Headlines